Physician profile
Christopher Daniel
NPI 1518177328
$233.81
in general payments reported to CMS, 2019-2025
7 companies · $57.56 in 2025
The $57.56 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6.26 · 2020: $32.30 · 2021: $27.56 · 2022: $50.63 · 2023: $30.12 · 2024: $29.38 · 2025: $57.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $59.50 | 2023-2024 | Collagenase Santyl |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.89 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $33.35 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $31.01 | 2020-2021 | |
| Becton, Dickinson and Company | $24.21 | 2025 | Powerglide |
| Janssen Pharmaceuticals, INC | $16.71 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.